Published in Clin Chest Med on December 01, 2011
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med (2015) 11.98
Tracing the cellular origin of cancer. Nat Cell Biol (2013) 1.75
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400. Clin Cancer Res (2015) 1.35
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. Oncotarget (2014) 1.05
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res (2014) 1.01
The pivotal role of pathology in the management of lung cancer. J Thorac Dis (2013) 1.01
Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. J Hum Genet (2014) 0.97
Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. J Thorac Oncol (2014) 0.92
Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients. BMC Cancer (2015) 0.91
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer. Clin Cancer Res (2015) 0.88
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors. Invest New Drugs (2014) 0.88
Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. PLoS One (2014) 0.86
Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma. Int J Oncol (2015) 0.85
Genomics of squamous cell lung cancer. Oncologist (2013) 0.85
GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis. Oncotarget (2015) 0.85
Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type? Oncotarget (2015) 0.85
Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung. Oncologist (2016) 0.83
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Virchows Arch (2013) 0.83
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology. Front Oncol (2016) 0.83
Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma. Oncotarget (2016) 0.82
Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer. Mediators Inflamm (2016) 0.81
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis. Int J Clin Exp Pathol (2014) 0.80
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma. Int J Oncol (2015) 0.80
Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer. Sci Rep (2015) 0.80
Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis. Oncotarget (2016) 0.80
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation. J Cancer (2015) 0.79
Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer. Front Oncol (2017) 0.79
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake? Transl Lung Cancer Res (2016) 0.78
Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int (2015) 0.78
Prognostic value of decreased GRK6 expression in lung adenocarcinoma. J Cancer Res Clin Oncol (2016) 0.78
PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res (2016) 0.78
Classification of non-small cell lung cancer based on copy number alterations. PLoS One (2014) 0.77
MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2. Cancer Cell Int (2017) 0.77
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung. Transl Lung Cancer Res (2013) 0.77
Clinicopathological and immunohistochemical profile of non-small cell lung carcinoma in a tertiary care medical centre in South India. Lung India (2014) 0.77
The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. Oncotarget (2016) 0.77
Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review. Drug Des Devel Ther (2016) 0.77
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. PLoS One (2015) 0.77
Quantifying the expression of tumor marker genes in lung squamous cell cancer with RNA sequencing. J Thorac Dis (2014) 0.77
Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation. Oncotarget (2016) 0.76
Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Oncotarget (2016) 0.76
Lung cancer transcriptomes refined with laser capture microdissection. Am J Pathol (2014) 0.76
Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma. Biomed Res Int (2015) 0.76
ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma. Cell Death Dis (2016) 0.75
Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review. Oncotarget (2016) 0.75
Factors associated with disease-specific survival of patients with non-small cell lung cancer. J Bras Pneumol (2016) 0.75
The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma. BMC Pulm Med (2015) 0.75
Nestin servers as a promising prognostic biomarker in non-small cell lung cancer. Am J Transl Res (2017) 0.75
Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma. Cancer Sci (2016) 0.75
Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer. J Thorac Dis (2016) 0.75
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2. Nat Commun (2017) 0.75
Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice. BMC Res Notes (2015) 0.75
Emerging challenges of advanced squamous cell lung cancer. ESMO Open (2016) 0.75
The continuing role of epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung. Transl Lung Cancer Res (2016) 0.75
Efficacy of short-term nivolumab treatment in a Chinese patient with relapsed advanced-stage lung squamous cell carcinoma: A case report. Medicine (Baltimore) (2016) 0.75
Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma. Med Sci Monit (2017) 0.75
Asthma and the risk of lung cancer: a meta-analysis. Oncotarget (2017) 0.75
Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis. Transl Oncol (2017) 0.75
Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: An autopsy study. Ann Thorac Med (2017) 0.75
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer (2017) 0.75
Targeting FGFR in Squamous Cell Carcinoma of the Lung. Target Oncol (2017) 0.75